Skip to main content

Table 3 Cost-Effectiveness ratios for each strategy modeled.

From: Cost-effectiveness of six strategies for Helicobacter pyloridiagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern

Strategy

Cost per symptom free year (95% CI*)

Empiric PPI Trial

122.13 (120.00-124.88)

Stool Ag

123.23 (120.68-125.58)

IgG serology

125.76 (123.18-128.27)

IgG serology w/reflex to Stool Ag

126.17 (123.43-128.08)

Breath test

128.31 (125.69-130.72)

IgG/IgA binary serology

129.04 (126.43-131.48)

  1. Numerical values are in $US per symptom-free year.